<?xml-stylesheet type="text/xsl" href="ViewNLM-v2.3.xsl"?><!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Korean Med Sci</journal-id><journal-id journal-id-type="publisher-id">JKMS</journal-id><journal-title-group><journal-title>Journal of Korean Medical Science</journal-title></journal-title-group><issn pub-type="ppub">1011-8934</issn><issn pub-type="epub">1598-6357</issn><publisher><publisher-name>The Korean Academy of Medical Sciences</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.3346/jkms.2004.19.3.407</article-id><article-id pub-id-type="pmid">15201508</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Association between Bone Mineral Density and LDL Receptor-Related Protein 5 Gene Polymorphisms in Young Korean Men</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Koh</surname><given-names>Jung-Min</given-names></name><xref ref-type="aff" rid="A1"/></contrib><contrib contrib-type="author"><name><surname>Jung</surname><given-names>Min Hui</given-names></name><xref ref-type="aff" rid="A2">*</xref></contrib><contrib contrib-type="author"><name><surname>Hong</surname><given-names>Jeong Soo</given-names></name><xref ref-type="aff" rid="A2">*</xref></contrib><contrib contrib-type="author"><name><surname>Park</surname><given-names>Hyung Joo</given-names></name><xref ref-type="aff" rid="A1"/></contrib><contrib contrib-type="author"><name><surname>Chang</surname><given-names>Jae Suk</given-names></name><xref ref-type="aff" rid="A3">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Shin</surname><given-names>Hyoung Doo</given-names></name><xref ref-type="aff" rid="A5">&#x02225;</xref></contrib><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Shin-Yoon</given-names></name><xref ref-type="aff" rid="A4">&#x02021;</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Kim</surname><given-names>Ghi Su</given-names></name><xref ref-type="aff" rid="A1"/></contrib></contrib-group><aff id="A1">Department of Genetic Epidemiology SNP Genetics, Seoul, Republic of Korea.</aff><aff id="A2"><label>*</label>Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.</aff><aff id="A3"><label>&#x02020;</label>Department of Orthopedic Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.</aff><aff id="A4"><label>&#x02021;</label>Department of Orthopedic Surgery, Kyungpook National University, Taegu, Republic of Korea.</aff><aff id="A5"><label>&#x02225;</label>Asan Institute for Life Sciences, Seoul, Republic of Korea.</aff><author-notes><corresp> Address for correspondence: Ghi Su Kim, M.D. Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, 388-1 Poongnap-dong, Songpa-gu, Seoul 138-736, Korea. Tel: +82.2-3010-3242, Fax: +82.2-3010-6962, <email>gskim3@amc.seoul.kr</email></corresp></author-notes><pub-date pub-type="ppub"><month>6</month><year>2004</year></pub-date><pub-date pub-type="epub"><day>30</day><month>6</month><year>2004</year></pub-date><volume>19</volume><issue>3</issue><fpage>407</fpage><lpage>412</lpage><history><date date-type="received"><day>15</day><month>12</month><year>2003</year></date><date date-type="accepted"><day>27</day><month>2</month><year>2004</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2004 The Korean Academy of Medical Sciences</copyright-statement><copyright-year>2004</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0">http://creativecommons.org/licenses/by-nc/3.0</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Recently, It has been reported that the LDL receptor-related protein 5 (LRP5) regulates bone formation, and that mutations of the gene cause osteoporosis-pseudoglioma syndrome or high bone mass phenotypes. However, the mutations cannot explain a genetic trait for osteoporosis in the general population because of their rarity. From 219 Korean men aged 20-34 yr, we looked for six known polymorphisms causing amino acid changes in the LRP5 coding region, and investigated their association with bone mineral density (BMD) at the following anatomical sites: lumbar spine (L2-L4) and the left proximal femur (femoral neck, Ward's triangle, trochanter and shaft). We found that the Q89R polymorphism was significantly associated with BMD at the femoral neck and Ward's triangle (<italic>p</italic>=0.004 and &#x0003c;0.001, respectively). However, after adjusting for age, weight and height, a statistically significant association only occurred at the Ward's triangle (<italic>p</italic>=0.043), and a marginal association was observed at the femoral neck (<italic>p</italic>=0.098). No A400V, V667M, R1036Q and A1525V polymorphisms were found, and no statistically significant association was found between the A1330V polymorphism and BMD at any sites. Although we failed to demonstrate a clear association between the <italic>LRP5</italic> polymorphism and peak bone mass in young men, the present study suggests that larger-scale studies on the Q89R polymorphism need to be performed.</p></abstract><kwd-group><kwd>LDL-Receptor Related Proteins</kwd><kwd>Polymorphism (Genetic)</kwd><kwd>Osteoporosis</kwd><kwd>Bone Density</kwd><kwd>Men</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>INTRODUCTION</title><p>Although osteoporosis is more generally considered as a disease that afflicts women, it is also prevalent in men. The incidence of osteoporotic fractures in men is about half of that in women (<xref ref-type="bibr" rid="B1">1</xref>). Furthermore, the mortality associated with hip fracture in elderly men is considerably higher than in women (<xref ref-type="bibr" rid="B2">2</xref>). However, the cellular and molecular basis underlying male osteoporosis is still poorly understood due to the emphasis on osteoporosis in women (<xref ref-type="bibr" rid="B3">3</xref>).</p><p>Peak bone mass, which is recognized as an important determinant in development of osteoporosis (<xref ref-type="bibr" rid="B4">4</xref>), is under strong genetic control, and genetic influences have been estimated to account for about 75% of the inter-individual variability in peak bone mass (<xref ref-type="bibr" rid="B5">5</xref>). Although many genes have been examined for their association with bone mass, most studies were carried out in either women or populations of older subjects of an age when accretion of bone mass has ceased and bone loss has begun (<xref ref-type="bibr" rid="B6">6</xref>). Genetic studies in men with peak bone mass are relatively rare (<xref ref-type="bibr" rid="B3">3</xref>).</p><p>LDL receptor-related protein 5 (LRP5) has emerged as a key regulator of osteoblast proliferation and bone formation (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B8">8</xref>). Loss-of-function mutations of the <italic>LRP5</italic> gene cause the autosomal recessive osteoporosis pseudoglioma syndrome (OPPG), a disorder causing both congenital osteoporosis and eye abnormalities (<xref ref-type="bibr" rid="B7">7</xref>), while autosomal dominant high bone mass (HBM) traits result from a gain-of-function mutation of the gene that causes a glycine-to-valine amino acid change (G171V) (<xref ref-type="bibr" rid="B9">9</xref>-<xref ref-type="bibr" rid="B11">11</xref>). Collectively, these studies suggest that the <italic>LRP5</italic> gene is an important regulator of peak bone mass in vertebrates, although genetic mutations causing OPPG syndrome or HBM phenotype are very rare in the general population (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B11">11</xref>).</p><p>It has been suggested that a common polymorphism in the <italic>LRP5</italic> gene might contribute to genetic variations in bone mass in the general community (<xref ref-type="bibr" rid="B12">12</xref>). Torus palatinus, which was observed in subjects with the G171V mutation of the <italic>LRP5</italic> gene, is commonly detected in the general population (<xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B14">14</xref>), and this was reported to serve as a physical marker of high bone mineral density (BMD) in Caucasians (<xref ref-type="bibr" rid="B13">13</xref>) and Japanese (<xref ref-type="bibr" rid="B15">15</xref>). More importantly, several quantitative trait locus (QTL) analyses reported that the region 11q12-13, which contains the <italic>LRP5</italic> gene, strongly contributes to the normal variation of BMD in the general population (<xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B17">17</xref>). However, there is no information on whether <italic>LRP5</italic> polymorphisms are associated with BMD in the general community.</p><p>Recently, two mutation analyses reported seven and forty-two LRP5 gene polymorphisms in Japanese (<xref ref-type="bibr" rid="B18">18</xref>) and Caucasians (<xref ref-type="bibr" rid="B19">19</xref>), respectively. In the present study, we examined LRP5 gene coding region polymorphisms in young Korean men. We determined the frequency of occurrence of six polymorphisms causing amino acid changes, and investigated whether these polymorphisms were associated with BMD.</p></sec><sec sec-type="methods"><title>MATERIALS AND METHODS</title><sec><title>Subjects</title><p>The study population comprised 219 healthy young men who were medical students of University of Ulsan or residents at a university hospital (Asan Medical Center (AMC)) in Seoul, Korea. All subjects were Korean and volunteered for the study. The study was approved by the AMC ethics review committee and written informed consent was obtained from all subjects. Subjects completed a self-administered questionnaire concerning demographic characteristics, general health status, medication, weekly duration of weight-bearing physical activity, and smoking and alcohol drinking habits. Daily dietary calcium intake was assessed using a food frequency questionnaire (<xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B21">21</xref>). All subjects were free from drugs and diseases known to affect bone metabolism.</p></sec><sec><title>Bone mineral densitometry</title><p>All BMD (g/cm<sup>2</sup>) measurements of the lumbar spine (L2-L4, A-P) and the left proximal femur (femoral neck, Ward's triangle, trochanter and shaft) were measured by the same trained technician using a Lunar Corp. Expert XL (Lunar, Madison, WI, U.S.A.) dual energy radiography absorptiometer (software version 1.90). The in vivo precision of the machine was 0.82% for the lumbar spine, 1.12% for the femoral neck and 2.17% for Ward's triangle.</p></sec><sec><title>Genotype analysis with polymerase chain reaction and restriction fragment length polymorphism analysis</title><p>Genomic DNA was extracted from peripheral blood leukocytes using a commercial kit (Wizard Genomic DNA purification kit, Promega, Madison, WI, U.S.A.). Genotyping of DNA sequence variants in the Q89R and A1330V sites was carried out by restriction enzyme analysis of polymerase chain reaction (PCR)-amplified DNA using specific pairs of oligonucleotide primers, as described previously (<xref ref-type="bibr" rid="B18">18</xref>). The PCR primers were sequence-specific and/or mutated for convenience. Amplification of polymorphisms was carried out using a thermocycler (Perkin-Elmer, Boston, MA, U.S.A.) using a method described previously with some modifications (<xref ref-type="bibr" rid="B18">18</xref>). After amplification, PCR products were digested with restriction endonucleases <italic>Ava</italic>II and <italic>Dra</italic>III (New England Biolabs Inc., Beverly, MA, U.S.A.) for the Q89R and A1330V polymorphisms, respectively. The DNA fragments were then electrophoresed on 2% and 3% agarose gels for the Q89R and A1330V polymorphisms, respectively.</p><p>Because previously reported restriction enzyme analyses of polymerase chain reaction (PCR) were not available, genotyping for A400V, V667M, R1036Q and A1525V polymorphisms was performed by SNP-IT&#x02122; assays using the SNP stream 25K&#x02122; System (Orchid Biosciences, New Jersey, U.S.A.) (<xref ref-type="bibr" rid="B22">22</xref>). Briefly, the genomic DNA region spanning the polymorphic site was PCR-amplified using one phosphothiolated primer and one regular PCR primer. The amplified PCR products were then digested with exonuclease, with the 5' phosphothiolates protecting one strand of the PCR product from digestion. The single-strand PCR template generated by exonuclease digestion was overlaid onto a 384-well plate that was precoated covalently with the primer extension SNP-IT&#x02122; primers. These SNP-IT&#x02122; primers were designed to hybridize immediately adjacent to the polymorphic site. The PCR primer sequences are listed in <xref ref-type="table" rid="T1">Table 1</xref>. After hybridization of template strands, SNP-IT&#x02122; primers were then extended by a single base with DNA polymerase at the polymorphic site of interest. The extension mixtures contained two labeled terminating nucleotides (one FITC, one biotin) and two unlabeled terminating nucleotides. The final single base incorporated was identified with serial colorimetric reactions with anti-FITC-AP or streptavidin-HRP. The results of blue and/or yellow color developments were analyzed using an ELISA reader, and the final genotyping (allele) calls were made using the QCReview&#x02122; program. To confirm polymorphisms identified using SNP-IT&#x02122; assays, direct DNA sequencing was performed on 20 samples using a fluorescence-based automated DNA sequencer, as previously described (<xref ref-type="bibr" rid="B19">19</xref>). The PCR primer sequences used for direct sequencing are listed in <xref ref-type="table" rid="T1">Table 1</xref>. The PCR products were directly sequenced on both strands using an ABI Prism 377 DNA sequencer (Perkin Elmer, CA, U.S.A.). No discrepancies were found between direct sequencing data and SNP-IT&#x02122; data (data not shown).</p></sec><sec><title>Statistical analysis</title><p>Descriptive characteristics are expressed as mean and standard deviation. The independent contribution of the clinical characteristics to BMD was determined using multiple linear regression analysis. Linkage disequilibrium between genotypes and significance of deviation from the Hardy-Weinberg equilibrium were analyzed by the &#x003c7;<sup>2</sup> test. Haplotypes were constructed using the E-M algorithm (Arlequin, <ext-link ext-link-type="uri" xlink:href="http://anthro.unige.ch/arlequin/">http://anthro.unige.ch/arlequin/</ext-link>). The effect of single or combined genotypes on BMD was evaluated using either unpaired t-tests or one-way analyses of variance. Multiple linear regression analyses were performed to adjust for risk factors, with BMD as a dependent variable, and genotypes, age, weight and height each being independent variables. Unless indicated otherwise, <italic>p</italic> values less than 0.05 were considered significant. The SPSS 10.0 program (SPSS Inc., Chicago, IL, U.S.A.) was used for statistical procedures.</p></sec></sec><sec sec-type="results"><title>RESULTS</title><sec><title>Subject characteristics</title><p>The mean age of participants was 25.6&#x000b1;3.7 yr (range 20-34 yr). Body mass index was 22.9&#x000b1;2.8 kg/m<sup>2</sup> (range 17.2-32.1 kg/m<sup>2</sup>). Multiple linear regression analysis showed a positive association between body weight and BMD at all anatomical sites: &#x003b2;=0.275, <italic>p</italic>=0.001 at the lumbar spine; &#x003b2;=0.253, <italic>p</italic>=0.001 at the femoral neck; &#x003b2;=0.216, <italic>p</italic>=0.004 at the Ward's triangle; &#x003b2;=0.329, <italic>p</italic>&#x0003c;0.001 at the trochanter; &#x003b2;=0.299, <italic>p</italic>&#x0003c;0.001 at the femoral shaft. Age was negatively correlated with BMD at the proximal femur, with regression analysis showing &#x003b2;=-0.312, <italic>p</italic>&#x0003c;0.001 at the femoral neck; &#x003b2;=-0.349, <italic>p</italic>&#x0003c;0.001 at the Ward's triangle; &#x003b2;=-0.192, <italic>p</italic>=0.010 at the trochanter; and &#x003b2;=-0.223, <italic>p</italic>=0.003 at the femoral shaft. There was no association between BMD and height, calcium intake, smoking, alcohol consumption or exercise (data not shown).</p></sec><sec><title>Genotype frequencies</title><p>The genotype distributions and allele frequencies for <italic>LRP5</italic> gene polymorphisms are presented in <xref ref-type="table" rid="T2">Table 2</xref>. No polymorphisms of the A400V, V667M, R1036Q or A1525V type were observed. These data differ from those obtained from Caucasian subjects (<xref ref-type="bibr" rid="B19">19</xref>). We detected Q89R and A1330V polymorphisms, and these occurred at allelic frequencies comparable to those previously reported in Japanese studies (<xref ref-type="bibr" rid="B18">18</xref>). The Q89R and A1330V polymorphisms were in Hardy-Weinberg equilibrium. Because the number of subjects bearing the VV genotype of the A1330V polymorphism was so small (n=7), we compared those carrying the V allele (AV or VV) with those that did not (AA). Contradictory to the previous result suggesting that the two polymorphisms were in another linkage disequilibrium blocks in European (<xref ref-type="bibr" rid="B23">23</xref>), the distribution of combination genotypes indicated that the two polymorphisms were in linkage disequilibrium in our subjects (&#x003c7;<sup>2</sup>=19.526, <italic>p</italic>&#x0003c;0.001). The haplotype frequencies were: QA, 357 (81.5%); QV, 44 (10.0%); RA, 16 (3.7%); RV, 21 (4.8%). Combined genotypes were constructed from the haplotypes and their frequencies were: QA-QA, 145 (66.2%); QA-QV, 32 (14.6%); QA-RA, 16 (7.3%); QA-RV, 19 (8.7%); QV-QV, 5 (2.3%); QV-RV, 2 (0.9%).</p></sec><sec><title>Association between <italic>LRP5</italic> gene polymorphisms and BMD</title><p>The study population data were separated into two categories on the basis of Q89R or A1330V polymorphisms in the <italic>LRP5</italic> gene. No significant differences in any clinical parameters were observed between the two groups (<xref ref-type="table" rid="T3">Table 3</xref>). However, subjects with the QQ genotype had significantly higher BMD at the femoral neck and Ward's triangle, compared with those with the QR genotype (<italic>p</italic>=0.004 and <italic>p</italic>&#x0003c;0.001, respectively). Lumbar BMD was not different between the two groups. Multiple linear regression analyses were undertaken in order to adjust confounding variables such as age, weight and height. The Q89R polymorphism was significantly associated with BMD at the Ward's triangle (<italic>p</italic>=0.043), and marginally associated at the femoral neck (<italic>p</italic>=0.098) (<xref ref-type="table" rid="T4">Table 4</xref>).</p><p>When the study subjects were divided into two groups according to the presence of the V allele of the A1330V polymorphism, those with the V allele (AV or VV genotype) had lower body weight than those without (AA genotype) (<italic>p</italic>=0.035, <xref ref-type="table" rid="T3">Table 3</xref>). Other clinical parameters were similar between the two groups (data not shown). No differences in BMD values at any sites were noted between these two groups both before (<xref ref-type="table" rid="T3">Table 3</xref>) and after (<xref ref-type="table" rid="T4">Table 4</xref>) adjusting for confounding variables.</p><p>We also examined effects of the combined genotypes on BMD. The subjects were divided into three groups according to the number of QA haplotypes: (QA haplotype=2)=(1, 1), (QA haplotype=1)=(1, 0), and (QA haplotype=0)=(0, 0). No associations between the combined genotypes and BMD were noted at any sites before or after adjusting for confounding variables (data not shown).</p></sec></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>To our knowledge, this is the first study examining the association between <italic>LRP5</italic> gene polymorphisms and BMD in the general population. We observed a statistically significant association between the Q89R polymorphism and BMD at Ward's triangle after adjusting for confounding variables. This association may have to be viewed with circumspection. The precision error for Ward's triangle measurement is considerably higher than for other regions of interest (<xref ref-type="bibr" rid="B24">24</xref>, <xref ref-type="bibr" rid="B25">25</xref>). Further, the association was not noted at the lumbar spine, which has similar compositions of cortical and trabecular bone to the Ward's triangle. These suggest that the significant association may result from false positive one. However, the association was suggested at the femoral neck, albeit marginal (<italic>p</italic>=0.098). Therefore, we cannot exclude a possibility that this somewhat weak association is due to the small sample size providing insufficient statistical power to show modest but statistically significant associations.</p><p>The association of the Q89R polymorphism with BMD appears to be further supported by the position at which this polymorphism is situated in the <italic>LRP5</italic> gene. The <italic>LRP5</italic> gene contains 23 exons and spans &#x0003e;100 kb (<xref ref-type="bibr" rid="B26">26</xref>). The LRP5 protein consists of a distinct ensemble of five structural motifs-four structures resembling a propeller with six blades containing YWTD spacer repeat domains, epidermal growth factor-like repeats, an LDL receptor-like ligand-binding domain, a single transmembrane domain, and a short cytoplasmic tail (<xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B28">28</xref>). The Q89R polymorphism is located in exon 2 encoding the first of four propellers, while the A1330V polymorphism is in exon 18 encoding the LDL receptor-like domain. Although the precise function of each region is uncertain, the four propellers are of structural importance. It has been suggested that mutation in the first propeller region can alter the local hydrophobic environment, thus possibly affecting the interaction of LRP5 with other proteins (<xref ref-type="bibr" rid="B11">11</xref>). In addition, a number of mutations in this region in the LDL receptor propeller module can cause familial hypercholesterolemia (<xref ref-type="bibr" rid="B28">28</xref>), confirming that this domain is important for protein function. These suggest a possibility that the Q89R or related linked polymorphisms coding the region might alter LRP5 protein function and might be associated with BMD, suggesting need for further studies on functional differences of these polymorphisms in relation to bone metabolism.</p><p>In the present study we observed different genetic backgrounds between Koreans and Caucasians with respect to allele frequencies of <italic>LRP5</italic> gene polymorphisms. The allele frequencies of the A400V, V667M, R1036Q and A1525V polymorphisms in Caucasians were 2-8% (<xref ref-type="bibr" rid="B19">19</xref>), whereas no such polymorphisms were found in our subjects. More importantly, the Q89R polymorphism was very rare in Caucasians (<xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B29">29</xref>), whereas the polymorphism was prevalent in Japanese (<xref ref-type="bibr" rid="B18">18</xref>) and our Korean subjects. These data suggest that the Q89R polymorphism would not be a useful marker for bone mass in Caucasians.</p><p>In conclusion, we failed to demonstrate a clear association between the <italic>LRP5</italic> polymorphism and peak bone mass in young men. However, the present study suggests that larger-scale studies on the Q89R polymorphism are needed.</p></sec></body><back><fn-group><fn fn-type="supported-by"><p>This work was supported by a grant from the Korea Health 21 R &#x00026; D Project, Ministry of Health &#x00026; Welfare, Republic of Korea (Project No. 01-PJ3-PG6-01GN11-0002).</p></fn></fn-group><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooper</surname><given-names>C</given-names></name><name><surname>Atkinson</surname><given-names>EJ</given-names></name><name><surname>O'Fallon</surname><given-names>WM</given-names></name><name><surname>Melton</surname><given-names>LJ</given-names><suffix>3rd</suffix></name></person-group><article-title>Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989</article-title><source>J Bone Miner Res</source><year>1992</year><volume>7</volume><fpage>221</fpage><lpage>227</lpage><pub-id pub-id-type="pmid">1570766</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Myers</surname><given-names>AH</given-names></name><name><surname>Robinson</surname><given-names>EG</given-names></name><name><surname>Van Natta</surname><given-names>ML</given-names></name><name><surname>Michelson</surname><given-names>JD</given-names></name><name><surname>Collins</surname><given-names>K</given-names></name><name><surname>Baker</surname><given-names>SP</given-names></name></person-group><article-title>Hip fractures among the elderly: factors associated with in-hospital mortality</article-title><source>Am J Epidemiol</source><year>1991</year><volume>134</volume><fpage>1128</fpage><lpage>1137</lpage><pub-id pub-id-type="pmid">1746523</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Byers</surname><given-names>RJ</given-names></name><name><surname>Hoyland</surname><given-names>JA</given-names></name><name><surname>Braidman</surname><given-names>IP</given-names></name></person-group><article-title>Osteoporosis in men: a cellular endocrine perspective of an increasingly common clinical problem</article-title><source>J Endocrinol</source><year>2001</year><volume>168</volume><fpage>353</fpage><lpage>362</lpage><pub-id pub-id-type="pmid">11241167</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newton-John</surname><given-names>HF</given-names></name><name><surname>Morgan</surname><given-names>DB</given-names></name></person-group><article-title>The loss of bone with age, osteoporosis, and fractures</article-title><source>Clin Orthop</source><year>1970</year><volume>71</volume><fpage>229</fpage><lpage>252</lpage><pub-id pub-id-type="pmid">5433385</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heaney</surname><given-names>RP</given-names></name><name><surname>Abrams</surname><given-names>S</given-names></name><name><surname>Dawson-Hughes</surname><given-names>B</given-names></name><name><surname>Looker</surname><given-names>A</given-names></name><name><surname>Marcus</surname><given-names>R</given-names></name><name><surname>Matkovic</surname><given-names>V</given-names></name><name><surname>Weaver</surname><given-names>C</given-names></name></person-group><article-title>Peak bone mass</article-title><source>Osteoporos Int</source><year>2000</year><volume>11</volume><fpage>985</fpage><lpage>1009</lpage><pub-id pub-id-type="pmid">11256898</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ralston</surname><given-names>SH</given-names></name></person-group><article-title>Genetic control of susceptibility to osteoporosis</article-title><source>J Clin Endocrinol Metab</source><year>2002</year><volume>87</volume><fpage>2460</fpage><lpage>2466</lpage><pub-id pub-id-type="pmid">12050200</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gong</surname><given-names>Y</given-names></name><name><surname>Slee</surname><given-names>RB</given-names></name><name><surname>Fukai</surname><given-names>N</given-names></name><name><surname>Rawadi</surname><given-names>G</given-names></name><name><surname>Roman-Roman</surname><given-names>S</given-names></name><name><surname>Reginato</surname><given-names>AM</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Cundy</surname><given-names>T</given-names></name><name><surname>Glorieux</surname><given-names>FH</given-names></name><name><surname>Lev</surname><given-names>D</given-names></name><name><surname>Zacharin</surname><given-names>M</given-names></name><name><surname>Oexle</surname><given-names>K</given-names></name><name><surname>Marcelino</surname><given-names>J</given-names></name><name><surname>Suwairi</surname><given-names>W</given-names></name><name><surname>Heeger</surname><given-names>S</given-names></name><name><surname>Sabatakos</surname><given-names>G</given-names></name><name><surname>Apte</surname><given-names>S</given-names></name><name><surname>Adkins</surname><given-names>WN</given-names></name><name><surname>Allgrove</surname><given-names>J</given-names></name><name><surname>Arslan-Kirchner</surname><given-names>M</given-names></name><name><surname>Batch</surname><given-names>JA</given-names></name><name><surname>Beighton</surname><given-names>P</given-names></name><name><surname>Black</surname><given-names>GC</given-names></name><name><surname>Boles</surname><given-names>RG</given-names></name><name><surname>Boon</surname><given-names>LM</given-names></name><name><surname>Borrone</surname><given-names>C</given-names></name><name><surname>Brunner</surname><given-names>HG</given-names></name><name><surname>Carle</surname><given-names>GF</given-names></name><name><surname>Dallapiccola</surname><given-names>B</given-names></name><name><surname>De Paepe</surname><given-names>A</given-names></name><name><surname>Floege</surname><given-names>B</given-names></name><name><surname>Halfhide</surname><given-names>ML</given-names></name><name><surname>Hall</surname><given-names>B</given-names></name><name><surname>Hennekam</surname><given-names>RC</given-names></name><name><surname>Hirose</surname><given-names>T</given-names></name><name><surname>Jans</surname><given-names>A</given-names></name><name><surname>Juppner</surname><given-names>H</given-names></name><name><surname>Kim</surname><given-names>CA</given-names></name><name><surname>Keppler-Noreuil</surname><given-names>K</given-names></name><name><surname>Kohlschuetter</surname><given-names>A</given-names></name><name><surname>LaCombe</surname><given-names>D</given-names></name><name><surname>Lambert</surname><given-names>M</given-names></name><name><surname>Lemyre</surname><given-names>E</given-names></name><name><surname>Letteboer</surname><given-names>T</given-names></name><name><surname>Peltonen</surname><given-names>L</given-names></name><name><surname>Ramesar</surname><given-names>RS</given-names></name><name><surname>Romanengo</surname><given-names>M</given-names></name><name><surname>Somer</surname><given-names>H</given-names></name><name><surname>Steichen-Gersdorf</surname><given-names>E</given-names></name><name><surname>Steinmann</surname><given-names>B</given-names></name><name><surname>Sullivan</surname><given-names>B</given-names></name><name><surname>Superti-Furga</surname><given-names>A</given-names></name><name><surname>Swoboda</surname><given-names>W</given-names></name><name><surname>Van den Boogaard</surname><given-names>MJ</given-names></name><name><surname>Van Hul</surname><given-names>W</given-names></name><name><surname>Vikkula</surname><given-names>M</given-names></name><name><surname>Votruba</surname><given-names>M</given-names></name><name><surname>Zabel</surname><given-names>B</given-names></name><name><surname>Garcia</surname><given-names>T</given-names></name><name><surname>Baron</surname><given-names>R</given-names></name><name><surname>Olsen</surname><given-names>BR</given-names></name><name><surname>Warman</surname><given-names>ML</given-names></name></person-group><collab>Osteoporosis-Pseudoglioma Syndrome Collaborative Group</collab><article-title>LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development</article-title><source>Cell</source><year>2001</year><volume>107</volume><fpage>513</fpage><lpage>523</lpage><pub-id pub-id-type="pmid">11719191</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kato</surname><given-names>M</given-names></name><name><surname>Patel</surname><given-names>MS</given-names></name><name><surname>Levasseur</surname><given-names>R</given-names></name><name><surname>Lobov</surname><given-names>I</given-names></name><name><surname>Chang</surname><given-names>BH</given-names></name><name><surname>Glass</surname><given-names>DA</given-names><suffix>2nd</suffix></name><name><surname>Hartmann</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Hwang</surname><given-names>TH</given-names></name><name><surname>Brayton</surname><given-names>CF</given-names></name><name><surname>Lang</surname><given-names>RA</given-names></name><name><surname>Karsenty</surname><given-names>G</given-names></name><name><surname>Chan</surname><given-names>L</given-names></name></person-group><article-title>Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor</article-title><source>J Cell Biol</source><year>2002</year><volume>157</volume><fpage>303</fpage><lpage>314</lpage><pub-id pub-id-type="pmid">11956231</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Babij</surname><given-names>P</given-names></name><name><surname>Zhao</surname><given-names>W</given-names></name><name><surname>Small</surname><given-names>C</given-names></name><name><surname>Kharode</surname><given-names>Y</given-names></name><name><surname>Yaworsky</surname><given-names>PJ</given-names></name><name><surname>Bouxsein</surname><given-names>ML</given-names></name><name><surname>Reddy</surname><given-names>PS</given-names></name><name><surname>Bodine</surname><given-names>PV</given-names></name><name><surname>Robinson</surname><given-names>JA</given-names></name><name><surname>Bhat</surname><given-names>B</given-names></name><name><surname>Marzolf</surname><given-names>J</given-names></name><name><surname>Moran</surname><given-names>RA</given-names></name><name><surname>Bex</surname><given-names>F</given-names></name></person-group><article-title>High bone mass in mice expressing a mutant LRP5 gene</article-title><source>J Bone Miner Res</source><year>2003</year><volume>18</volume><fpage>960</fpage><lpage>974</lpage><pub-id pub-id-type="pmid">12817748</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyden</surname><given-names>LM</given-names></name><name><surname>Mao</surname><given-names>J</given-names></name><name><surname>Belsky</surname><given-names>J</given-names></name><name><surname>Mitzner</surname><given-names>L</given-names></name><name><surname>Farhi</surname><given-names>A</given-names></name><name><surname>Mitnick</surname><given-names>MA</given-names></name><name><surname>Wu</surname><given-names>D</given-names></name><name><surname>Insogna</surname><given-names>K</given-names></name><name><surname>Lifton</surname><given-names>RP</given-names></name></person-group><article-title>High bone density due to a mutation in LDL-receptor-related protein 5</article-title><source>N Engl J Med</source><year>2002</year><volume>346</volume><fpage>1513</fpage><lpage>1521</lpage><pub-id pub-id-type="pmid">12015390</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Little</surname><given-names>RD</given-names></name><name><surname>Carulli</surname><given-names>JP</given-names></name><name><surname>Del Mastro</surname><given-names>RG</given-names></name><name><surname>Dupuis</surname><given-names>J</given-names></name><name><surname>Osborne</surname><given-names>M</given-names></name><name><surname>Folz</surname><given-names>C</given-names></name><name><surname>Manning</surname><given-names>SP</given-names></name><name><surname>Swain</surname><given-names>PM</given-names></name><name><surname>Zhao</surname><given-names>SC</given-names></name><name><surname>Eustace</surname><given-names>B</given-names></name><name><surname>Lappe</surname><given-names>MM</given-names></name><name><surname>Spitzer</surname><given-names>L</given-names></name><name><surname>Zweier</surname><given-names>S</given-names></name><name><surname>Braunschweiger</surname><given-names>K</given-names></name><name><surname>Benchekroun</surname><given-names>Y</given-names></name><name><surname>Hu</surname><given-names>X</given-names></name><name><surname>Adair</surname><given-names>R</given-names></name><name><surname>Chee</surname><given-names>L</given-names></name><name><surname>FitzGerald</surname><given-names>MG</given-names></name><name><surname>Tulig</surname><given-names>C</given-names></name><name><surname>Caruso</surname><given-names>A</given-names></name><name><surname>Tzellas</surname><given-names>N</given-names></name><name><surname>Bawa</surname><given-names>A</given-names></name><name><surname>Franklin</surname><given-names>B</given-names></name><name><surname>McGuire</surname><given-names>S</given-names></name><name><surname>Nogues</surname><given-names>X</given-names></name><name><surname>Gong</surname><given-names>G</given-names></name><name><surname>Allen</surname><given-names>KM</given-names></name><name><surname>Anisowicz</surname><given-names>A</given-names></name><name><surname>Morales</surname><given-names>AJ</given-names></name><name><surname>Lomedico</surname><given-names>PT</given-names></name><name><surname>Recker</surname><given-names>SM</given-names></name><name><surname>Van Eerdewegh</surname><given-names>P</given-names></name><name><surname>Recker</surname><given-names>RR</given-names></name><name><surname>Johnson</surname><given-names>ML</given-names></name></person-group><article-title>A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait</article-title><source>Am J Hum Genet</source><year>2002</year><volume>70</volume><fpage>11</fpage><lpage>19</lpage><pub-id pub-id-type="pmid">11741193</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>MS</given-names></name><name><surname>Karsenty</surname><given-names>G</given-names></name></person-group><article-title>Regulation of bone formation and vision by LRP5</article-title><source>N Engl J Med</source><year>2002</year><volume>346</volume><fpage>1572</fpage><lpage>1574</lpage><pub-id pub-id-type="pmid">12015398</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belsky</surname><given-names>JL</given-names></name><name><surname>Hamer</surname><given-names>JS</given-names></name><name><surname>Hubert</surname><given-names>JE</given-names></name><name><surname>Insogna</surname><given-names>K</given-names></name><name><surname>Johns</surname><given-names>W</given-names></name></person-group><article-title>Torus palatinus: a new anatomical correlation with bone density in postmenopausal women</article-title><source>J Clin Endocrinol Metab</source><year>2003</year><volume>88</volume><fpage>2081</fpage><lpage>2086</lpage><pub-id pub-id-type="pmid">12727958</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolas</surname><given-names>S</given-names></name><name><surname>Halperin</surname><given-names>V</given-names></name><name><surname>Jerreris</surname><given-names>K</given-names></name><name><surname>Huddleston</surname><given-names>S</given-names></name><name><surname>Robinson</surname><given-names>HB</given-names></name></person-group><article-title>The occurrence of torus palatinus and torus mandibularis in 2,478 dental patients</article-title><source>Oral Surg Oral Med Oral Pathol</source><year>1953</year><volume>6</volume><fpage>1134</fpage><lpage>1141</lpage><pub-id pub-id-type="pmid">13088010</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hosoi</surname><given-names>T</given-names></name><name><surname>Yoda</surname><given-names>T</given-names></name><name><surname>Yamaguchi</surname><given-names>M</given-names></name><name><surname>Amano</surname><given-names>H</given-names></name><name><surname>Orimo</surname><given-names>H</given-names></name></person-group><article-title>Elderly women with oral exostoses had higher bone mineral density</article-title><source>J Bone Miner Metab</source><year>2003</year><volume>21</volume><fpage>120</fpage><lpage>122</lpage><pub-id pub-id-type="pmid">12601578</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koller</surname><given-names>DL</given-names></name><name><surname>Rodriguez</surname><given-names>LA</given-names></name><name><surname>Christian</surname><given-names>JC</given-names></name><name><surname>Slemenda</surname><given-names>CW</given-names></name><name><surname>Econs</surname><given-names>MJ</given-names></name><name><surname>Hui</surname><given-names>SL</given-names></name><name><surname>Morin</surname><given-names>P</given-names></name><name><surname>Conneally</surname><given-names>PM</given-names></name><name><surname>Joslyn</surname><given-names>G</given-names></name><name><surname>Curran</surname><given-names>ME</given-names></name><name><surname>Peacock</surname><given-names>M</given-names></name><name><surname>Johnston</surname><given-names>CC</given-names></name><name><surname>Foroud</surname><given-names>T</given-names></name></person-group><article-title>Linkage of a QTL contributing to normal variation in bone mineral density to chromosome 11q12-13</article-title><source>J Bone Miner Res</source><year>1998</year><volume>13</volume><fpage>1903</fpage><lpage>1908</lpage><pub-id pub-id-type="pmid">9844108</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koller</surname><given-names>DL</given-names></name><name><surname>Econs</surname><given-names>MJ</given-names></name><name><surname>Morin</surname><given-names>PA</given-names></name><name><surname>Christian</surname><given-names>JC</given-names></name><name><surname>Hui</surname><given-names>SL</given-names></name><name><surname>Parry</surname><given-names>P</given-names></name><name><surname>Curran</surname><given-names>ME</given-names></name><name><surname>Rodriguez</surname><given-names>LA</given-names></name><name><surname>Conneally</surname><given-names>PM</given-names></name><name><surname>Joslyn</surname><given-names>G</given-names></name><name><surname>Peacock</surname><given-names>M</given-names></name><name><surname>Johnston</surname><given-names>CC</given-names></name><name><surname>Foroud</surname><given-names>T</given-names></name></person-group><article-title>Genome screen for QTLs contributing to normal variation in bone mineral density and osteoporosis</article-title><source>J Clin Endocrinol Metab</source><year>2000</year><volume>85</volume><fpage>3116</fpage><lpage>3120</lpage><pub-id pub-id-type="pmid">10999795</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okubo</surname><given-names>M</given-names></name><name><surname>Horinishi</surname><given-names>A</given-names></name><name><surname>Kim</surname><given-names>DH</given-names></name><name><surname>Yamamoto</surname><given-names>TT</given-names></name><name><surname>Murase</surname><given-names>T</given-names></name></person-group><article-title>Seven novel sequence variants in the human low density lipoprotein receptor related protein 5 (LRP5) gene</article-title><source>Hum Mutat</source><year>2002</year><volume>19</volume><fpage>186</fpage><lpage>188</lpage><pub-id pub-id-type="pmid">11793484</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allen</surname><given-names>KM</given-names></name><name><surname>Anisowicz</surname><given-names>A</given-names></name><name><surname>FitzGerald</surname><given-names>MG</given-names></name><name><surname>Van Eerdewegh</surname><given-names>P</given-names></name><name><surname>Little</surname><given-names>RD</given-names></name><name><surname>Keith</surname><given-names>T</given-names></name><name><surname>Recker</surname><given-names>RR</given-names></name><name><surname>Johnson</surname><given-names>ML</given-names></name></person-group><article-title>Polymorphism analysis of LDL receptor-related protein 5 (LRP5)</article-title><source>J Bone Miner Res</source><year>2002</year><volume>17</volume><fpage>S424</fpage></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Willett</surname><given-names>WC</given-names></name><name><surname>Sampson</surname><given-names>L</given-names></name><name><surname>Stampfer</surname><given-names>MJ</given-names></name><name><surname>Rosner</surname><given-names>B</given-names></name><name><surname>Bain</surname><given-names>C</given-names></name><name><surname>Witschi</surname><given-names>J</given-names></name><name><surname>Hennekens</surname><given-names>CH</given-names></name><name><surname>Speizer</surname><given-names>FE</given-names></name></person-group><article-title>Reproducibility and validity of a semiquantitative food frequency questionnaire</article-title><source>Am J Epidemiol</source><year>1985</year><volume>122</volume><fpage>51</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">4014201</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Won</surname><given-names>HS</given-names></name><name><surname>Kim</surname><given-names>WY</given-names></name></person-group><article-title>Development and validation of a semi-quantitative food frequency questionnaire to evaluate nutritional status of Korean elderly</article-title><source>Korean J Nutr</source><year>2000</year><volume>33</volume><fpage>314</fpage><lpage>323</lpage><comment>(in Korean)</comment></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>JK</given-names></name><name><surname>Kim</surname><given-names>HT</given-names></name><name><surname>Cho</surname><given-names>SM</given-names></name><name><surname>Kim</surname><given-names>KH</given-names></name><name><surname>Jin</surname><given-names>HJ</given-names></name><name><surname>Ryu</surname><given-names>GM</given-names></name><name><surname>Oh</surname><given-names>B</given-names></name><name><surname>Park</surname><given-names>C</given-names></name><name><surname>Kimm</surname><given-names>K</given-names></name><name><surname>Jo</surname><given-names>SA</given-names></name><name><surname>Jung</surname><given-names>SC</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>In</surname><given-names>SM</given-names></name><name><surname>Lee</surname><given-names>JE</given-names></name><name><surname>Jo</surname><given-names>I</given-names></name></person-group><article-title>Characterization of 458 single nucleotide polymorphisms of disease candidate genes in the Korean population</article-title><source>J Hum Genet</source><year>2003</year><volume>48</volume><fpage>213</fpage><lpage>216</lpage><pub-id pub-id-type="pmid">12768436</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Twells</surname><given-names>RC</given-names></name><name><surname>Mein</surname><given-names>CA</given-names></name><name><surname>Phillips</surname><given-names>MS</given-names></name><name><surname>Hess</surname><given-names>JF</given-names></name><name><surname>Veijola</surname><given-names>R</given-names></name><name><surname>Gilbey</surname><given-names>M</given-names></name><name><surname>Bright</surname><given-names>M</given-names></name><name><surname>Metzker</surname><given-names>M</given-names></name><name><surname>Lie</surname><given-names>BA</given-names></name><name><surname>Kingsnorth</surname><given-names>A</given-names></name><name><surname>Gregory</surname><given-names>E</given-names></name><name><surname>Nakagawa</surname><given-names>Y</given-names></name><name><surname>Snook</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>WY</given-names></name><name><surname>Masters</surname><given-names>J</given-names></name><name><surname>Johnson</surname><given-names>G</given-names></name><name><surname>Eaves</surname><given-names>I</given-names></name><name><surname>Howson</surname><given-names>JM</given-names></name><name><surname>Clayton</surname><given-names>D</given-names></name><name><surname>Cordell</surname><given-names>HJ</given-names></name><name><surname>Nutland</surname><given-names>S</given-names></name><name><surname>Rance</surname><given-names>H</given-names></name><name><surname>Carr</surname><given-names>P</given-names></name><name><surname>Todd</surname><given-names>JA</given-names></name></person-group><article-title>Haplotype structure, LD blocks, and uneven recombination within the LRP5 gene</article-title><source>Genome Res</source><year>2003</year><volume>13</volume><fpage>845</fpage><lpage>855</lpage><pub-id pub-id-type="pmid">12727905</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mazess</surname><given-names>RB</given-names></name><name><surname>Barden</surname><given-names>H</given-names></name><name><surname>Ettinger</surname><given-names>M</given-names></name><name><surname>Schultz</surname><given-names>E</given-names></name></person-group><article-title>Bone density of the radius, spine, and proximal femur in osteoporosis</article-title><source>J Bone Miner Res</source><year>1988</year><volume>3</volume><fpage>13</fpage><lpage>18</lpage><pub-id pub-id-type="pmid">3213603</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pouilles</surname><given-names>JM</given-names></name><name><surname>Tremollieres</surname><given-names>F</given-names></name><name><surname>Todorovsky</surname><given-names>N</given-names></name><name><surname>Ribot</surname><given-names>C</given-names></name></person-group><article-title>Precision and sensitivity of dual-energy x-ray absorptiometry in spinal osteoporosis</article-title><source>J Bone Miner Res</source><year>1991</year><volume>6</volume><fpage>997</fpage><lpage>1002</lpage><pub-id pub-id-type="pmid">1789144</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hey</surname><given-names>PJ</given-names></name><name><surname>Twells</surname><given-names>RC</given-names></name><name><surname>Phillips</surname><given-names>MS</given-names></name><name><surname>Nakagawa</surname><given-names>Y</given-names></name><name><surname>Brown</surname><given-names>SD</given-names></name><name><surname>Kawaguchi</surname><given-names>Y</given-names></name><name><surname>Cox</surname><given-names>R</given-names></name><name><surname>Xie</surname><given-names>G</given-names></name><name><surname>Dugan</surname><given-names>V</given-names></name><name><surname>Hammond</surname><given-names>H</given-names></name><name><surname>Metzker</surname><given-names>ML</given-names></name><name><surname>Todd</surname><given-names>JA</given-names></name><name><surname>Hess</surname><given-names>JF</given-names></name></person-group><article-title>Cloning of a novel member of the low-density lipoprotein receptor family</article-title><source>Gene</source><year>1998</year><volume>216</volume><fpage>103</fpage><lpage>111</lpage><pub-id pub-id-type="pmid">9714764</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Springer</surname><given-names>TA</given-names></name></person-group><article-title>An extracellular beta-propeller module predicted in lipoprotein and scavenger receptors, tyrosine kinases, epidermal growth factor precursor, and extracellular matrix components</article-title><source>J Mol Biol</source><year>1998</year><volume>283</volume><fpage>837</fpage><lpage>862</lpage><pub-id pub-id-type="pmid">9790844</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeon</surname><given-names>H</given-names></name><name><surname>Meng</surname><given-names>W</given-names></name><name><surname>Takagi</surname><given-names>J</given-names></name><name><surname>Eck</surname><given-names>MJ</given-names></name><name><surname>Springer</surname><given-names>TA</given-names></name><name><surname>Blacklow</surname><given-names>SC</given-names></name></person-group><article-title>Implications for familial hypercholesterolemia from the structure of the LDL receptor YWTD-EGF domain pair</article-title><source>Nat Struct Biol</source><year>2001</year><volume>8</volume><fpage>499</fpage><lpage>504</lpage><pub-id pub-id-type="pmid">11373616</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Wesenbeeck</surname><given-names>L</given-names></name><name><surname>Cleiren</surname><given-names>E</given-names></name><name><surname>Gram</surname><given-names>J</given-names></name><name><surname>Beals</surname><given-names>RK</given-names></name><name><surname>Benichou</surname><given-names>O</given-names></name><name><surname>Scopelliti</surname><given-names>D</given-names></name><name><surname>Key</surname><given-names>L</given-names></name><name><surname>Renton</surname><given-names>T</given-names></name><name><surname>Bartels</surname><given-names>C</given-names></name><name><surname>Gong</surname><given-names>Y</given-names></name><name><surname>Warman</surname><given-names>ML</given-names></name><name><surname>De Vernejoul</surname><given-names>MC</given-names></name><name><surname>Bollerslev</surname><given-names>J</given-names></name><name><surname>Van Hul</surname><given-names>W</given-names></name></person-group><article-title>Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density</article-title><source>Am J Hum Genet</source><year>2003</year><volume>72</volume><fpage>763</fpage><lpage>771</lpage><pub-id pub-id-type="pmid">12579474</pub-id></element-citation></ref></ref-list></back><floats-group><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Primer sequences for SNP-IT&#x02122; assays and for direct sequencing within the LDL receptor-related protein 5 gene</p></caption><graphic xlink:href="jkms-19-407-i001"/></table-wrap><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Genotype distribution and allele frequencies of polymorphisms of the LDL receptor-related protein 5 gene</p></caption><graphic xlink:href="jkms-19-407-i002"/><table-wrap-foot><fn><p><sup>*</sup>Values represent number of times the allele was detected (% of all subjects). <sup>&#x02020;</sup>Deviation from the Hardy-Weinberg equilibrium as determined by &#x003c7;<sup>2</sup> test. A <italic>p</italic> value &#x0003e;0.05 indicates the genotypes are in Hardy-Weinberg equilibrium.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Comparison of clinical characteristics and BMD (g/cm<sup>2</sup>). The study population was separated into two groups on the basis of having either the Q89R or A1330V polymorphism in the LDL receptor-related protein 5 gene</p></caption><graphic xlink:href="jkms-19-407-i003"/><table-wrap-foot><fn><p>All values are mean&#x000b1;SD. Differences in clinical characteristics between the two groups were tested using unpaired t-tests, where: <sup>*</sup><italic>p</italic>&#x0003c;0.005 vs. QQ; <sup>&#x02020;</sup><italic>p</italic>&#x0003c;0.001 vs. QQ; <sup>&#x02021;</sup><italic>p</italic>&#x0003c;0.05 vs. AA.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T4" position="float"><label>Table 4</label><caption><p>Multiple linear regression analysis with BMD as the dependent variable, and age, weight, height and genotypes as the independent variables</p></caption><graphic xlink:href="jkms-19-407-i004"/><table-wrap-foot><fn><p><sup>*</sup>NS denotes not significant.</p></fn></table-wrap-foot></table-wrap></floats-group></article>